Neighbor of Brca1 gene (Nbr1) functions as a negative regulator of postnatal osteoblastic bone formation and p38 MAPK activity

The neighbor of Brca1 gene (Nbr1) functions as an autophagy receptor involved in targeting ubiquitinated proteins for degradation. It also has a dual role as a scaffold protein to regulate growth-factor receptor and downstream signaling pathways. We show that genetic truncation of murine Nbr1 leads to an age-dependent increase in bone mass and bone mineral density through increased osteoblast differentiation and activity. At 6 mo of age, despite normal body size, homozygous mutant animals (Nbr1tr/tr) have ~50% more bone than littermate controls. Truncated Nbr1 (trNbr1) co-localizes with p62, a structurally similar interacting scaffold protein, and the autophagosome marker LC3 in osteoblasts, but unlike the full-length protein, trNbr1 fails to complex with activated p38 MAPK. Nbr1tr/tr osteoblasts and osteoclasts show increased activation of p38 MAPK, and significantly, pharmacological inhibition of the p38 MAPK pathway in vitro abrogates the increased osteoblast differentiation of Nbr1tr/tr cells. Nbr1 truncation also leads to increased p62 protein expression. We show a role for Nbr1 in bone remodeling, where loss of function leads to perturbation of p62 levels and hyperactivation of p38 MAPK that favors osteoblastogenesis.

[1]  M. Williamson,et al.  Dimerisation of the UBA domain of p62 inhibits ubiquitin binding and regulates NF-kappaB signalling. , 2010, Journal of molecular biology.

[2]  M. Vidal,et al.  Edgetic perturbation models of human inherited disorders , 2009, Molecular systems biology.

[3]  M. Yekezare,et al.  Spred2 interaction with the late endosomal protein NBR1 down-regulates fibroblast growth factor receptor signaling , 2009, The Journal of cell biology.

[4]  J. Baik,et al.  CIB1 functions as a Ca2+-sensitive modulator of stress-induced signaling by targeting ASK1 , 2009, Proceedings of the National Academy of Sciences.

[5]  G. Karsenty,et al.  Genetic control of bone formation. , 2009, Annual review of cell and developmental biology.

[6]  G. Mann,et al.  Enhanced neointimal hyperplasia and carotid artery remodelling in sequestosome 1 deficient mice , 2009, Journal of cellular and molecular medicine.

[7]  Mathias Gautel,et al.  Interactions with LC3 and polyubiquitin chains link nbr1 to autophagic protein turnover , 2009, FEBS letters.

[8]  M. Komatsu,et al.  A role for NBR1 in autophagosomal degradation of ubiquitinated substrates. , 2009, Molecular cell.

[9]  M. Fukayama,et al.  Periostin, a novel marker of intramembranous ossification, is expressed in fibrous dysplasia and in c-Fos-overexpressing bone lesions. , 2009, Human pathology.

[10]  G. Karsenty Transcriptional control of skeletogenesis. , 2008, Annual review of genomics and human genetics.

[11]  L. Hocking,et al.  Genetics and aetiology of Pagetic disorders of bone. , 2008, Archives of biochemistry and biophysics.

[12]  A. Saito,et al.  Specific regulation of cytokine-dependent p38 MAP kinase activation by p62/SQSTM1. , 2007, Journal of biochemistry.

[13]  G. Bjørkøy,et al.  p62/SQSTM1 Binds Directly to Atg8/LC3 to Facilitate Degradation of Ubiquitinated Protein Aggregates by Autophagy* , 2007, Journal of Biological Chemistry.

[14]  C. H. Goh,et al.  p38 mitogen-activated protein kinase regulates osteoblast differentiation through osterix. , 2007, Endocrinology.

[15]  S. Ralston,et al.  p62 mutations, ubiquitin recognition and Paget's disease of bone. , 2006, Biochemical Society transactions.

[16]  M. Diaz-Meco,et al.  Cell signaling and function organized by PB1 domain interactions. , 2006, Molecular cell.

[17]  G. Bjørkøy,et al.  p62/SQSTM1: A Missing Link between Protein Aggregates and the Autophagy Machinery , 2006, Autophagy.

[18]  J. Auwerx,et al.  Mature-onset obesity and insulin resistance in mice deficient in the signaling adapter p62. , 2006, Cell metabolism.

[19]  G. Bjørkøy,et al.  p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death , 2005, The Journal of cell biology.

[20]  S. L. Wong,et al.  Towards a proteome-scale map of the human protein–protein interaction network , 2005, Nature.

[21]  Thomas Sejersen,et al.  The Kinase Domain of Titin Controls Muscle Gene Expression and Protein Turnover , 2005, Science.

[22]  L. Hocking,et al.  Loss of Ubiquitin‐Binding Associated With Paget's Disease of Bone p62 (SQSTM1) Mutations , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[23]  L. Hocking,et al.  Novel UBA Domain Mutations of SQSTM1 in Paget's Disease of Bone: Genotype Phenotype Correlation, Functional Analysis, and Structural Consequences , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  C. Nobes,et al.  Regulation of Osteoblast Differentiation by Pasteurella Multocida Toxin (PMT): A Role for Rho GTPase in Bone Formation , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  E. Solomon,et al.  Brca1 expression is regulated by a bidirectional promoter that is shared by the Nbr1 gene in mouse. , 2004, Gene.

[26]  J. Lemonnier,et al.  Activation of p38 Mitogen‐Activated Protein Kinase and c‐Jun‐NH2‐Terminal Kinase by BMP‐2 and Their Implication in the Stimulation of Osteoblastic Cell Differentiation , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[27]  G. Bjørkøy,et al.  Interaction Codes within the Family of Mammalian Phox and Bem1p Domain-containing Proteins* , 2003, Journal of Biological Chemistry.

[28]  Gideon A. Rodan,et al.  Control of osteoblast function and regulation of bone mass , 2003, Nature.

[29]  L. Hocking,et al.  Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. , 2002, Human molecular genetics.

[30]  Jacques P. Brown,et al.  Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. , 2002, American journal of human genetics.

[31]  C. Cooper,et al.  Incidence and Natural History of Paget's Disease of Bone in England and Wales , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  F. Lallemand,et al.  Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. , 2001, Bone.

[33]  D. Goeddel,et al.  Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. , 1997, Immunity.

[34]  R. Oreffo,et al.  Modulation of osteogenesis and adipogenesis by human serum in human bone marrow cultures. , 1997, European journal of cell biology.

[35]  E. Solomon,et al.  Isolation of the murine Nbr1 gene adjacent to the murine Brca1 gene. , 1996, Genomics.

[36]  J. Aubin,et al.  Analysis of chondroprogenitor frequency and cartilage differentiation in a novel family of clonal chondrogenic rat cell lines. , 1996, Differentiation; research in biological diversity.

[37]  J. Strominger,et al.  Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[38]  R. Baron,et al.  Wnt signaling: a key regulator of bone mass. , 2006, Current topics in developmental biology.

[39]  P. Sharpe,et al.  NBR1 interacts with fasciculation and elongation protein zeta-1 (FEZ1) and calcium and integrin binding protein (CIB) and shows developmentally restricted expression in the neural tube. , 2002, European journal of biochemistry.

[40]  D. Wilkinson In situ hybridization: a practical approach , 1998 .